S Korean COVID-19 treatment ‘conditionally’ approved

SEOUL (Xinhua) – South Korea’s drug safety agency said on Friday  it conditionally approved the country’s first homegrown COVID-19 treatment candidate, developed by local pharmaceutical giant Celltrion. More details in Saturday’s Borneo Bulletin.